264
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial

, , , , , , , , , , , & show all
Pages 1045-1052 | Received 17 Nov 2016, Accepted 11 Aug 2017, Published online: 21 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Yongliang Feng, Jianmin Wang, Zhihong Shao, Zhuanzhuan Chen, Tian Yao, Shuang Dong, Yuanting Wu, Xiaohong Shi, Jing Shi, Guangming Liu, Jingen Bai, Hongping Guo, Hongting Liu, Xiaofeng Wu, Liming Liu, Xiaohui Song, Jiangtao Zhu, Suping Wang & Xiaofeng Liang. (2021) Predicting related factors of immunological response to hepatitis B vaccine in hemodialysis patients based on integration of decision tree classification and logistic regression. Human Vaccines & Immunotherapeutics 17:9, pages 3214-3220.
Read now
Yongliang Feng, Tian Yao, Yujie Han, Jing Shi, Shuang Dong, Yuanting Wu, Zhihong Shao, Hongting Liu, Hongping Guo, Guowei Chai, Liming Liu, Fuzhen Wang, Jianmin Wang, Xiaofeng Liang & Suping Wang. (2021) Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial. Expert Review of Vaccines 20:6, pages 743-751.
Read now
Tian Yao, Yuanting Wu, Shuang Dong, Linying Gao, Shan Shi, Zhihong Shao, Lina Wu, Dan Feng, Jing Shi, Yawei Zhang, Yongliang Feng, Xiaofeng Liang & Suping Wang. (2020) Long-term durability of immunogenicity induced by standard and triple-dose hepatitis B vaccine in patients receiving methadone maintenance treatment. Expert Review of Vaccines 19:9, pages 785-794.
Read now
Siyue Jia, Jingxin Li, Yuanbao Liu & Fengcai Zhu. (2020) Precision immunization: a new trend in human vaccination. Human Vaccines & Immunotherapeutics 16:3, pages 513-522.
Read now

Articles from other publishers (4)

Doaa Mohammed Youssef, Amal S. El-Shal, Rabab M. Elbehidy, Mohamed Adel Fouda, Sally M. Shalaby, Lamiaa Lotfy El Hawy, Abdelrahman Fathi Elsadek, Mayy Abd Alfattah Neemat-Allah, Seham M. Ramadan, Amal Gohary, Faika Arab, Mona Alsharkawy, Sabry Abdel Rahman Tolba, Mohamed Mohamed Abdelsalam, Ezzat Kamel Amin & Mona Hamed Gehad. (2023) Hepatitis B Immunization Status in Children with Chronic Kidney Disease: Experience at a Single Center, Egypt. Journal of Clinical Medicine 12:5, pages 1864.
Crossref
Ivan Fan-Ngai Hung, Desmond Yat-Hin Yap, Terence Pok-Siu Yip, Ricky Ruiqi Zhang, Kelvin Kai-Wang To, Kwok-Hung Chan, Sydney Chi-Wai Tang, Sing-Leung Lui, Yotam Levin, Efrat Kochba, Johnson Yiu-Nam Lau, Man-Fung Yuen, Tak-Mao Chan & Kwok-Yung Yuen. (2021) A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis. Clinical Infectious Diseases 73:2, pages e304-e311.
Crossref
Tian Yao, Zhihong Shao, Lina Wu, Shuang Dong, Linying Gao, Yuanting Wu, Xiaohong Shi, Jing Shi, Guangming Liu, Jianmin Wang, Huilin Zhao, Hongping Guo, Hongting Liu, Xiaofeng Wu, Liming Liu, Xiaohui Song, Jiangtao Zhu, Yawei Zhang, Yongliang Feng, Xiaofeng Liang & Suping Wang. (2021) Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China. Vaccine 39:18, pages 2537-2544.
Crossref
Tara Vinyette Saco, Alexandra T. Strauss & Dennis K. Ledford. (2018) Hepatitis B vaccine nonresponders. Annals of Allergy, Asthma & Immunology 121:3, pages 320-327.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.